Literature DB >> 23012123

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Faecal occult blood testing.

S P Halloran1, G Launoy, M Zappa.   

Abstract

Multidisciplinary, evidence-based guidelines for quality assurance in colorectal cancer screening and diagnosis have been developed by experts in a project coordinated by the International Agency for Research on Cancer. The full guideline document covers the entire process of population-based screening. It consists of 10 chapters and over 250 recommendations, graded according to the strength of the recommendation and the supporting evidence. The 450-page guidelines and the extensive evidence base have been published by the European Commission. The chapter on faecal occult blood testing includes 21 graded recommendations. The content of the chapter is presented here to promote international discussion and collaboration by making the principles and standards recommended in the new EU Guidelines known to a wider professional and scientific community. Following these recommendations has the potential to enhance the control of colorectal cancer through improvement in the quality and effectiveness of screening programmes and services. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23012123     DOI: 10.1055/s-0032-1309791

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  38 in total

Review 1.  Faecal occult blood testing for colorectal cancer screening: the past or the future.

Authors:  Sally C Benton; Helen E Seaman; Stephen P Halloran
Journal:  Curr Gastroenterol Rep       Date:  2015-02

2.  Fecal immunochemical test-based colorectal cancer screening: The gender dilemma.

Authors:  Esmée J Grobbee; Els Wieten; Bettina E Hansen; Esther M Stoop; Thomas R de Wijkerslooth; Iris Lansdorp-Vogelaar; Patrick M Bossuyt; Evelien Dekker; Ernst J Kuipers; Manon Cw Spaander
Journal:  United European Gastroenterol J       Date:  2016-07-14       Impact factor: 4.623

3.  European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.

Authors:  L von Karsa; J Patnick; N Segnan; W Atkin; S Halloran; I Lansdorp-Vogelaar; N Malila; S Minozzi; S Moss; P Quirke; R J Steele; M Vieth; L Aabakken; L Altenhofen; R Ancelle-Park; N Antoljak; A Anttila; P Armaroli; S Arrossi; J Austoker; R Banzi; C Bellisario; J Blom; H Brenner; M Bretthauer; M Camargo Cancela; G Costamagna; J Cuzick; M Dai; J Daniel; E Dekker; N Delicata; S Ducarroz; H Erfkamp; J A Espinàs; J Faivre; L Faulds Wood; A Flugelman; S Frkovic-Grazio; B Geller; L Giordano; G Grazzini; J Green; C Hamashima; C Herrmann; P Hewitson; G Hoff; I Holten; R Jover; M F Kaminski; E J Kuipers; J Kurtinaitis; R Lambert; G Launoy; W Lee; R Leicester; M Leja; D Lieberman; T Lignini; E Lucas; E Lynge; S Mádai; J Marinho; J Maučec Zakotnik; G Minoli; C Monk; A Morais; R Muwonge; M Nadel; L Neamtiu; M Peris Tuser; M Pignone; C Pox; M Primic-Zakelj; J Psaila; L Rabeneck; D Ransohoff; M Rasmussen; J Regula; J Ren; G Rennert; J Rey; R H Riddell; M Risio; V Rodrigues; H Saito; C Sauvaget; A Scharpantgen; W Schmiegel; C Senore; M Siddiqi; D Sighoko; R Smith; S Smith; S Suchanek; E Suonio; W Tong; S Törnberg; E Van Cutsem; L Vignatelli; P Villain; L Voti; H Watanabe; J Watson; S Winawer; G Young; V Zaksas; M Zappa; R Valori
Journal:  Endoscopy       Date:  2012-12-04       Impact factor: 10.093

Review 4.  Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.

Authors:  Tobias Niedermaier; Korbinian Weigl; Michael Hoffmeister; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2017-06-30       Impact factor: 8.082

5.  Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.

Authors:  Clasine M de Klerk; Lisanne M Vendrig; Patrick M Bossuyt; Evelien Dekker
Journal:  Am J Gastroenterol       Date:  2018-08-29       Impact factor: 10.864

6.  Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening.

Authors:  Esmée J Grobbee; Atija Kapidzic; Anneke J van Vuuren; Monique van Leerdam; Iris Lansdorp-Vogelaar; Caspar W N Looman; Marco J Bruno; Ernst J Kuipers; Manon C W Spaander
Journal:  Am J Gastroenterol       Date:  2015-06-09       Impact factor: 10.864

7.  Diagnostic value of fecal B cell activating factor in patients with abdominal discomfort.

Authors:  C Xie; R Quan; L Wang; C Chen; W Yan; Y Fu
Journal:  Clin Exp Immunol       Date:  2019-08-05       Impact factor: 4.330

8.  A fluorescent microsphere-based immunochromatographic strip is effective for quantitative fecal blood testing in colorectal cancer screening.

Authors:  Qingbing Wang; Jiwu Wang; Zeru Xiao; Zhiling Shen; Yanjun Wang; Yong Zhang; Tianyuan Pan; Jianan Xiao; Xiyuan Sun
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 3.940

9.  Academic hospital staff compliance with a fecal immunochemical test-based colorectal cancer screening program.

Authors:  Georgia Vlachonikolou; Paraskevas Gkolfakis; Athanasios D Sioulas; Ioannis S Papanikolaou; Anastasia Melissaratou; Giannis-Aimant Moustafa; Eleni Xanthopoulou; Gerasimos Tsilimidos; Ioanna Tsironi; Paraskevas Filippidis; Chrysoula Malli; George D Dimitriadis; Konstantinos Triantafyllou
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

10.  Fecal immunochemical test for hemoglobin in combination with fecal transferrin in colorectal cancer screening.

Authors:  Anton Gies; Katarina Cuk; Petra Schrotz-King; Hermann Brenner
Journal:  United European Gastroenterol J       Date:  2018-06-12       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.